However, it is important to note that the study does not provide data regarding the genetic backgrounds of the selected sporadic AD patients, such as ethnicity, gender, genetic risk scores, APOE genotype, age, AD Braak stage, and Clinical Dementia Rating (CDR) at the time of biopsy. The gene discussed is APOE; the disease is Alzheimer disease.